Cargando…

Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU

BACKGROUND: Sepsis induces the release of lipid mediators, which control both lipid metabolism and inflammation. However, the role of serum apolipoprotein A-V (ApoA5) in sepsis is poorly understood in pediatric patients. METHODS: ApoA5 was screened from serum proteomics profile in lipopolysaccharide...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chunxia, Cui, Yun, Miao, Huijie, Xiong, Xi, Dou, Jiaying, Shao, Lujing, Tang, Xiaomeng, Zhang, Yucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157801/
https://www.ncbi.nlm.nih.gov/pubmed/32322166
http://dx.doi.org/10.1155/2020/8052954
_version_ 1783522424845762560
author Wang, Chunxia
Cui, Yun
Miao, Huijie
Xiong, Xi
Dou, Jiaying
Shao, Lujing
Tang, Xiaomeng
Zhang, Yucai
author_facet Wang, Chunxia
Cui, Yun
Miao, Huijie
Xiong, Xi
Dou, Jiaying
Shao, Lujing
Tang, Xiaomeng
Zhang, Yucai
author_sort Wang, Chunxia
collection PubMed
description BACKGROUND: Sepsis induces the release of lipid mediators, which control both lipid metabolism and inflammation. However, the role of serum apolipoprotein A-V (ApoA5) in sepsis is poorly understood in pediatric patients. METHODS: ApoA5 was screened from serum proteomics profile in lipopolysaccharide- (LPS-) treated mice for 2 h, 24 h, and controls. Then, we conducted a prospective pilot study, and patients with sepsis admitted to a pediatric intensive care unit (PICU) were enrolled from January 2018 to December 2018. Serum ApoA5 levels on PICU admission were determined using enzyme-linked immunosorbent assays (ELISA). Blood samples from 30 healthy children were used as control. The correlation of ApoA5 with the clinical and laboratory parameters was analyzed. Logistic regression analyses and receiver operating characteristic curve (ROC) analysis were used to investigate the potential role of serum ApoA5 as a prognostic predictor for PICU mortality in pediatric patients with sepsis. RESULTS: A total of 101 patients with sepsis were enrolled in this study. The PICU mortality rate was 10.9% (11/101). Serum ApoA5 levels on PICU admission were significantly lower in nonsurvivors with sepsis compared with survivors (P = 0.009). In subgroup analysis, serum levels of ApoA5 were significantly correlated with sepsis-associated multiple organ dysfunction syndrome (MODS) (P < 0.001), shock (P = 0.002), acute kidney injury (AKI) (P < 0.001), acute liver injury (ALI) (P = 0.002), and gastrointestinal (GI) dysfunction (P = 0.012), but not respiratory failure, brain injury, and pathogenic species (all P > 0.05). Correlation analyses revealed significant correlations of serum ApoA5 with Ca(2+) concentration. Remarkably, the area under ROC curve (AUC) for serum ApoA5 levels on PICU admission was 0.789 for prediction of PICU mortality with a sensitivity of 75% and a specificity of 84.5% at a threshold value of 822 ng/mL. CONCLUSIONS: Serum ApoA5 level is associated with sepsis-associated shock, AKI, ALI, GI dysfunction, or MODS in children. Moreover, the findings of the present study suggest a prognostic value of ApoA5 in children with sepsis, and lower serum ApoA5 than 822 ng/mL predicts worse outcome in pediatric sepsis.
format Online
Article
Text
id pubmed-7157801
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71578012020-04-22 Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU Wang, Chunxia Cui, Yun Miao, Huijie Xiong, Xi Dou, Jiaying Shao, Lujing Tang, Xiaomeng Zhang, Yucai Mediators Inflamm Research Article BACKGROUND: Sepsis induces the release of lipid mediators, which control both lipid metabolism and inflammation. However, the role of serum apolipoprotein A-V (ApoA5) in sepsis is poorly understood in pediatric patients. METHODS: ApoA5 was screened from serum proteomics profile in lipopolysaccharide- (LPS-) treated mice for 2 h, 24 h, and controls. Then, we conducted a prospective pilot study, and patients with sepsis admitted to a pediatric intensive care unit (PICU) were enrolled from January 2018 to December 2018. Serum ApoA5 levels on PICU admission were determined using enzyme-linked immunosorbent assays (ELISA). Blood samples from 30 healthy children were used as control. The correlation of ApoA5 with the clinical and laboratory parameters was analyzed. Logistic regression analyses and receiver operating characteristic curve (ROC) analysis were used to investigate the potential role of serum ApoA5 as a prognostic predictor for PICU mortality in pediatric patients with sepsis. RESULTS: A total of 101 patients with sepsis were enrolled in this study. The PICU mortality rate was 10.9% (11/101). Serum ApoA5 levels on PICU admission were significantly lower in nonsurvivors with sepsis compared with survivors (P = 0.009). In subgroup analysis, serum levels of ApoA5 were significantly correlated with sepsis-associated multiple organ dysfunction syndrome (MODS) (P < 0.001), shock (P = 0.002), acute kidney injury (AKI) (P < 0.001), acute liver injury (ALI) (P = 0.002), and gastrointestinal (GI) dysfunction (P = 0.012), but not respiratory failure, brain injury, and pathogenic species (all P > 0.05). Correlation analyses revealed significant correlations of serum ApoA5 with Ca(2+) concentration. Remarkably, the area under ROC curve (AUC) for serum ApoA5 levels on PICU admission was 0.789 for prediction of PICU mortality with a sensitivity of 75% and a specificity of 84.5% at a threshold value of 822 ng/mL. CONCLUSIONS: Serum ApoA5 level is associated with sepsis-associated shock, AKI, ALI, GI dysfunction, or MODS in children. Moreover, the findings of the present study suggest a prognostic value of ApoA5 in children with sepsis, and lower serum ApoA5 than 822 ng/mL predicts worse outcome in pediatric sepsis. Hindawi 2020-01-13 /pmc/articles/PMC7157801/ /pubmed/32322166 http://dx.doi.org/10.1155/2020/8052954 Text en Copyright © 2020 Chunxia Wang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Chunxia
Cui, Yun
Miao, Huijie
Xiong, Xi
Dou, Jiaying
Shao, Lujing
Tang, Xiaomeng
Zhang, Yucai
Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU
title Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU
title_full Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU
title_fullStr Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU
title_full_unstemmed Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU
title_short Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU
title_sort apolipoprotein a-v is a novel diagnostic and prognostic predictor in pediatric patients with sepsis: a prospective pilot study in picu
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157801/
https://www.ncbi.nlm.nih.gov/pubmed/32322166
http://dx.doi.org/10.1155/2020/8052954
work_keys_str_mv AT wangchunxia apolipoproteinavisanoveldiagnosticandprognosticpredictorinpediatricpatientswithsepsisaprospectivepilotstudyinpicu
AT cuiyun apolipoproteinavisanoveldiagnosticandprognosticpredictorinpediatricpatientswithsepsisaprospectivepilotstudyinpicu
AT miaohuijie apolipoproteinavisanoveldiagnosticandprognosticpredictorinpediatricpatientswithsepsisaprospectivepilotstudyinpicu
AT xiongxi apolipoproteinavisanoveldiagnosticandprognosticpredictorinpediatricpatientswithsepsisaprospectivepilotstudyinpicu
AT doujiaying apolipoproteinavisanoveldiagnosticandprognosticpredictorinpediatricpatientswithsepsisaprospectivepilotstudyinpicu
AT shaolujing apolipoproteinavisanoveldiagnosticandprognosticpredictorinpediatricpatientswithsepsisaprospectivepilotstudyinpicu
AT tangxiaomeng apolipoproteinavisanoveldiagnosticandprognosticpredictorinpediatricpatientswithsepsisaprospectivepilotstudyinpicu
AT zhangyucai apolipoproteinavisanoveldiagnosticandprognosticpredictorinpediatricpatientswithsepsisaprospectivepilotstudyinpicu